On May 28, 2020, Flex Ltd (Flex), a Singapore-based electronics manufacturer listed on the NASDAQ, disclosed in its 2020 US Securities and Exchange Commission (SEC) filing that it had initiated a voluntary self-disclosure to the US Office of Foreign Assets Control (OFAC) on February 14, 2019. The initial disclosure related to possible non-compliance with US sanctions by certain non-US companies affiliated with Flex. According to the SEC filing, an internal investigation is ongoing and Flex expects to complete the investigation and final disclosure to OFAC by the end of its second quarter of its fiscal year 2021.

We set out in our recent blog post some key messages, which may help you navigate complex issues of sanctions law.



Contact

Wilson Ang
Wilson Ang
Partner
Email
wilson.ang@nortonrosefulbright.com
T: +65 63095392

Practice areas:

Industries:

Recent publications

Publication

Understanding the impact of Medicare Advantage changes on providers

The Centers for Medicare and Medicaid (CMS) recently released important policy updates for the Medicare Advantage program, providing critical insights for providers into the new administration’s views on the Medicare Advantage program.

United States | April 16, 2025

Healthcare
biotech test tubes

Publication

Strategic asset search and evaluation in biopharma

Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.

United States | April 16, 2025

Life sciences and pharmaceuticals
Why SPACs offer a robust alternative to IPO market amidst looming global trade war

Publication

SPACs: Alternative to IPO market amid looming global trade war

President Trump’s recent tariffs appear to have direct implications for initial public offering (IPO) activity in what was forecasted to be a blockbuster year for such markets.

United States | April 15, 2025

Mergers and acquisitions
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now